Literature DB >> 23761728

Withdrawal: Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.

.   

Abstract

Entities:  

Year:  2013        PMID: 23761728      PMCID: PMC3675055     

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


× No keyword cloud information.
Due to duplicate publication of part of Figure 1c from [1] in Figure 5 of [2], the authors of have voluntarily withdrawn their article from Molecular Vision. The corresponding author of [2] was the first to bring this error to the attention of the Editors. He did so promptly, and it was he who first sought to withdraw the article.
  2 in total

1.  Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy.

Authors:  Sarbari Acharya; Fahima Dilnawaz; Sanjeeb K Sahoo
Journal:  Biomaterials       Date:  2009-07-23       Impact factor: 12.479

2.  Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.

Authors:  Moutushy Mitra; Ranjita Misra; Anju Harilal; Sanjeeb K Sahoo; Subramanian Krishnakumar
Journal:  Mol Vis       Date:  2011-10-19       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.